Eagle Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
CIP
EC
BCM
BG
Eagle Asset Management's TNDM Position: Q4 2022 in Review
Eagle Asset Management sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 520,778 shares — an estimated $24.9M sold.
Eagle Asset Management first reported a position in TNDM in Q3 2018 and held it in 11 quarters. The position peaked at $90.1M in Q3 2020. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.
- Eagle Asset Management reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
- Eagle Asset Management sold 520,778 Tandem Diabetes Care shares in Q4 2022, an estimated $24.9M.
- Eagle Asset Management first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 11 quarters.
- Eagle Asset Management's Tandem Diabetes Care position peaked at $90.1M in Q3 2020.
- 295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.
Based on Eagle Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.